According to SK Biopharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$0.72 Billion. an increase over the revenue in the year 2024 that were of A$0.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.